Recruiting × OTHER × Adenocarcinoma Of Esophagus × Clear all mFOLFIRINOX Versus mFOLFOX With or Without Nivolumab for the Treatment of Advanced, Unresectable, or Metastatic HER2 Negative Esophageal, Gastroesophageal Junction, and Gastric Adenocarcinoma
Phase 3 Recruiting
382 enrolled
OLIGOMETS
Phase 2 Recruiting
54 enrolled
Endeavor-1
Phase NA Recruiting
50 enrolled
A Study of Mesothelin-Targeted CAR T-Cell Therapy in People With Esophagogastric Cancer
Phase 1 Recruiting
18 enrolled
OPTIMUS
Phase NA Recruiting
50 enrolled
Minimally Invasive Molecular Approaches for the Diagnosis of Barrett's Esophagus and Esophageal Adenocarcinoma
Phase NA Recruiting
1,550 enrolled
TNT-OES-2
Phase 2 Recruiting
216 enrolled
NeoTISLEGA
Phase 1 Recruiting
18 enrolled
SOS4C
Phase NA Recruiting
400 enrolled
Barrett's Esophagitis in Anorexia Nervosa Binge/Purge Subtype
Recruiting
25 enrolled
A Study of agenT-797 in Combination With Botensilimab, Balstilimab, Ramucirumab, and Paclitaxel for People With Esophageal, Gastric, or Gastro-esophageal Junction Cancer
Phase 2 Recruiting
37 enrolled
GRACIE
Phase 2 Recruiting
88 enrolled
Multi-Site Detection of Barrett's Esophagus in Patients Without Chronic GERD Symptoms
Phase NA Recruiting
800 enrolled
PSI-Immune
Phase 2 Recruiting
480 enrolled
Chemotherapy With or Without Radiation or Surgery in Treating Participants With Oligometastatic Esophageal or Gastric Cancer
Phase 2 Recruiting
100 enrolled
MEMENTO
Phase 2 Recruiting
14 enrolled
Genetic Analysis-Guided Irinotecan Hydrochloride Dosing of mFOLFIRINOX in Treating Patients With Locally Advanced Gastroesophageal or Stomach Cancer
Phase 4 Recruiting
36 enrolled
LABS
Recruiting
100 enrolled
Anti-PD-1 mAb Plus Metabolic Modulator in Solid Tumor Malignancies
Phase 2 Recruiting
72 enrolled
LOGICAN
Phase 2 Recruiting
118 enrolled
Organ Preservation With Durvalumab-based Immunotherapy in Combination With Chemoradiation as Definitive Therapy for Early Stage Esophageal Adenocarcinoma With Indication for Radical Surgery
Phase 2 Recruiting
32 enrolled
AuspiCiOus
Phase 2 Recruiting
25 enrolled
SWAT-BE
Phase NA Recruiting
2,298 enrolled
Progression of Gastroesophageal Reflux Disease and Barrett's Esophagus and the Creation of a Barrett's Registry
Recruiting
3,000 enrolled
WATSEURO2
Recruiting
416 enrolled
TRAP-2
Phase 3 Recruiting
376 enrolled
ROBOT-2
Phase NA Recruiting
218 enrolled